MP
TLSIW icon

MSD Partners’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

MSD Partners’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-133,333
Closed -$217K – 18
2024
Q2 		$217K Hold
133,333
– – 0.02% 15
2024
Q1 		$133K Hold
133,333
– – 0.01% 16
2023
Q4 		$159K Hold
133,333
– – 0.01% 19
2023
Q3 		$50.7K Hold
133,333
– – ﹤0.01% 52
2023
Q2 		$5.59K Hold
133,333
– – ﹤0.01% 66
2023
Q1 		$8.19K Hold
133,333
– – ﹤0.01% 68
2022
Q4 		$10K Hold
133,333
– – ﹤0.01% 70
2022
Q3 		$8K Hold
133,333
– – ﹤0.01% 82
2022
Q2 		$11K Hold
133,333
– – ﹤0.01% 92
2022
Q1 		$34K Buy
+133,333
New +$57.3K ﹤0.01% 92

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

MSD Partners's TLSIW Position: Q3 2024 in Review

MSD Partners sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 133,333 shares — an estimated $217K sold.

MSD Partners first reported a position in TLSIW in Q1 2022 and held it in 10 quarters. The position peaked at $217K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • MSD Partners reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • MSD Partners sold 133,333 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $217K.
  • MSD Partners first reported a position in TriSalus Life Sciences Warrant in Q1 2022 and held it in 10 quarters.
  • MSD Partners's TriSalus Life Sciences Warrant position peaked at $217K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on MSD Partners's 13F filing for Q3 2024, filed 14 Nov 2024.